North America Veterinary Vaccines Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Veterinary Vaccines Market size is expected to reach US$ 4,251.2 Million by 2031 from US$ 3,064.3 Million in 2024. The market is estimated to record a CAGR of 4.8% from 2025 to 2031.

Executive Summary and North America Veterinary Vaccines Market Analysis:

The veterinary vaccines market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share, followed by Canada. Factors such as the growing demand for veterinary vaccines from healthcare market players, the increasing government support to provide cost-effective healthcare services, the rising strategic developments by the veterinary vaccine players to enhance services, and a growing healthcare industry that demands frameworks and guidelines based on real-world data for their business models contribute to this market.

North America Veterinary Vaccines Market: Strategic Insights

North America Veterinary Vaccines Market Segmentation Analysis:

• By Technology, the North America Veterinary Vaccines Market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others. Live Attenuated Vaccines held the largest share of the market in 2024.
• By Animal Type, the North America Veterinary Vaccines Market is segmented into Companion and Livestock & Poultry. Livestock and Poultry held the largest share of the market in 2024.
• By Companion, the North America Veterinary Vaccines Market is segmented into Dogs, Cat, Horses, and Others. Dogs held the largest share of the market in 2024.
• By Livestock and Poultry, the North America Veterinary Vaccines Market is segmented into Chicken, Cattle, and Others. Chicken held the largest share of the market in 2024.
• By Route of Administration, the North America Veterinary Vaccines Market is segmented into Intramuscular, Subcutaneous, and Others. Intramuscular held the largest share of the market in 2024.
• By End User, the North America Veterinary Vaccines Market is segmented into Veterinary Hospitals, Veterinary Clinics, and Others. Veterinary Hospitals held the largest share of the market in 2024.

North America Veterinary Vaccines Market Players Density: Understanding Its Impact on Business Dynamics

The North America Veterinary Vaccines Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Veterinary Vaccines Market Outlook

The increasing ownership of companion animals has heightened awareness regarding pet health and preventive care, ultimately raising the demand for vaccines that protect them from infectious diseases. According to the American Pet Products Association (APPA), the percentage of US households reported owning a pet increased from 67% in 2019 to 70% in 2022. According to the data from the American Veterinary Medical Association, about 59.8 million US households owned dogs, and 42.1 million US households owned cats as of 2024. Per the USDA, Latin America is the third-largest market for US-imported dog and cat food, fueled by economic growth from disinflation, lower interest rates, supportive export prices, and increased tourism. This economic boost enables consumers to invest more in pet care. Key markets for US pet food exports include Brazil, Peru, the Dominican Republic, Colombia, and Trinidad and Tobago. Since the COVID-19 pandemic, pet ownership has increased, and by 2023, the region had imported US$259 million worth of pet food, representing a 75% rise since 2020. The US accounts for 40% of this market, alongside the EU and Mexico as major exporters. These economies have seen a rise in pet adoption due to urbanization and higher disposable income.

In September 2022, the World Health Organization (WHO) promoted vaccination campaigns for zoonoses, such as rabies, that can pass from animals to humans. The WHO promotes elimination campaigns for rabies, which include the vaccination of dogs on a mass scale as a preventive measure. Such initiatives encourage vaccine acceptance in developed and developing regions. In conclusion, the rise in pet ownership and the increasing companion animal population are crucial growth drivers for the veterinary vaccines market. This trend is fueled by changing societal attitudes toward pets, increasing disposable income, and global initiatives to control zoonotic diseases. As the pet healthcare industry continues to evolve, the demand for effective vaccines is expected to grow.

North America Veterinary Vaccines Market Country Insights

By country, the North America Veterinary Vaccines Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

Livestock groups provide consumers with different products and services, including meat, milk, eggs, fiber, and draught power. Viral infection among livestock, companion animals, and others is a critical aspect of animal health in the country. The viruses infecting the animals spread at a faster rate. Thus, immunizations of animals from such viruses are of prime importance in animal healthcare in the country. Foot-and-mouth disease is a highly contagious viral disease that affects cloven-hoofed animals, such as cattle, pigs, sheep, and goats. While the US has been free of FMD for decades, outbreaks in other parts of the world, particularly in regions with close international trade and animal transport, present an ongoing risk. The US government and agriculture industry are ready to respond quickly if an outbreak occurs, with vaccines being essential for managing and controlling the disease.

According to the US Department of Agriculture, Animal and Plant Health Inspection Service (APHIS) invested ~US$ 42 million in foot-and-mouth disease vaccine antigen concentrate from private companies in 2022, with an additional US$ 30 million in 2023. The organization also acquired diagnostic kits to enhance its response to outbreaks. This US-only supply supported the vaccine which are available through the North American Foot-and-Mouth Disease Vaccine Bank.

In addition, the increasing pet ownership is driving up the demand for vaccinations for companion animals in the country. According to the 2023-2024 American Pet Products Association Survey, 66% of US households, which equates to 86.9 million households, own a pet. Moreover, the rise in research and development activities is expected to further boost the growth of the animal vaccines market in the coming years.

North America Veterinary Vaccines Market Company Profiles

Some of the key players operating in the market include Merck & Co. Inc., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Veterinary Vaccines Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise